Skip to content
Disclosery

ORBIMED ADVISORS LLC: LXEO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on LXEO, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 3,947,850 LXEO shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 3,947,850 shares
    Change vs previous 13F +345,400 shares

    0.35% of the 13F portfolio, value $18,377,242.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,602,450 shares
    Change vs previous 13F +1,477,450 shares

    0.45% of the 13F portfolio, value $20,678,063.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,125,000 shares
    Change vs previous 13F not available

    0.43% of the 13F portfolio, value $21,101,250.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).